Citations

Clear

19 citation(s) found for "Lewis, Jason".

WATS3D: An Interobserver Study of Barrett's Esophagus–Associated Dysplasia Among Gastrointestinal Pathologists
Patil, Deepa T. , Goldblum, John R. , Lauwers, Gregory Y. , Lewis, Jason T., Robert, Marie E. , Odze, Robert D. , Lewis, Jason T., Singer, Mendel E.

Mayo Clinic

Clinical and Translational Gastroenterology | December 13, 2023 | Volume: 15 | Issue: 2 | Pages: e00661

10.14309/ctg.0000000000000661 | PMID 38088399 Get It

INTRODUCTION: Wide-area transepithelial sampling with 3-dimensional computer-assisted analysis (WATS 3D ) has been shown to increase the detection rate of dysplasia (and intestinal metaplasia) in patients with Barrett's esophagus (BE). The purpose of this study was to evaluate the interobserver variability and accuracy of diagnosing BE-associated dysplasia in WATS 3D specimens among gastrointestinal (GI) pathologists without prior experience with this technology. METHODS: Five GI pathologists underwent a 4-hour in-person (at microscope) and virtual training session and then evaluated digital images of discrete cellular foci from 60 WATS 3D cases with BE (20 nondysplastic BE [NDBE], 20 low-grade dysplasia [LGD], and 20 high-grade dysplasia/esophageal adenocarcinoma [HGD/EAC]). Each case consisted of 1 hematoxylin and eosin–stained image (cell block), and 1 liquid cytology or papanicolaou-stained smear image (120 images in total). RESULTS: The overall kappa value among the 5 study pathologists was excellent (overall kappa = 0.93; kappa = 0.93 and 0.97 for cell block and smear specimens, respectively). There were no significant differences noted in kappa values in interpretation of the cell block vs smear specimens or in any of the individual diagnostic categories when the latter were evaluated separately. Furthermore, agreement was perfect (100%) regarding detection of neoplasia (either LGD, HGD, or EAC). Diagnoses were made with complete confidence in 91% of instances. DISCUSSION: We conclude that GI pathologists, without any prior experience in interpretation of WATS 3D specimens, can undergo a short training session and then diagnose these specimens with a very high level of accuracy and reproducibility.
Focal Nodular Hyperplasia and Focal Nodular Hyperplasia–like Lesions
LeGout, Jordan D. , Bolan, Candice W. , Bowman, Andrew W. , Caserta, Melanie P. , Chen, Frank K. , Cox, Kelly , Sanyal, Rupan , Toskich, Beau B. , Lewis, Jason T., Alexander, Lauren F. , Bowman, Andrew W , Alexander, Lauren F , Toskich, Beau , Lewis, Jason T.

Mayo Clinic

RadioGraphics | June 10, 2022 | Volume: 42 | Issue: 4 | Pages: 1043-1061

10.1148/rg.210156 | PMID 35687520 Get It

Pathology of Fibropolycystic Liver Diseases
Lewis, Jason

Mayo Clinic

Clinical Liver Disease | May 1, 2021 | Volume: 17 | Issue: 4 | Pages: 238-243

10.1002/cld.1044 | PMID 33968382 Get It

Nonimmunoglobulin Crystal-Storing Histiocytosis (CSH): Case Report and Literature Review
Beltran, Manuel , Khurana, Sharad , Gil, Yennifer, Lewis, Jason T., Foran, James M. , Foran, James M , Lewis, Jason T., Kumar, Rohit

Mayo Clinic

Case Reports in Hematology | October 20, 2020 | Volume: 2020 | Issue: No issue available | Pages: 1-4

10.1155/2020/8856411 | PMID 33133706 Get It

Crystal-storing histiocytosis (CSH) is an uncommon condition in which histiocytes accumulate a crystalline matter within their cytoplasm. Generally, those crystals are composed of either monoclonal or polyclonal immunoglobulin chains, which have a strong association with an underlying lymphoproliferative or plasma cell disorder (LP-PCD). Rarely, CSH has been reported as local or generalized manifestation of a variety of benign disorders. These cases are associated with crystals composed of nonimmunoglobulin substances. We are reporting an exceptional case of a local colonic CSH with Charcot–Leyden crystals. This patient underwent a screening colonoscopy that detected some polyps. The biopsy reported tubular adenomas, with a markedly dense, transmural inflammatory infiltrates, which were predominantly composed of eosinophils and crystal-storing histiocytes containing Charcot–Leyden crystals. The patient had a negative workup for LP-PCD and autoimmune conditions, including a normal skeletal survey and bone marrow aspirate/biopsy. The only positive laboratory workup was an elevated absolute eosinophil count and a positive IgG anti-Strongyloides antibody. Giving those findings, this parasitic infection is the most likely etiology of the CSH in our patient. Although there was an initial negative evaluation for LP-PCD, close monitoring of patients with either immunoglobulin or nonimmunoglobulin CSH is recommended.
Hepatocellular Carcinoma Detection by Plasma Methylated DNA: Discovery, Phase I Pilot, and Phase II Clinical Validation
Dukek, Brian A. , Kanipakam, Reddappa V.S.R., Ghoz, Hassan , Yab, Tracy C. , Giama, Nasra H., Onyirioha, Kristeen, Abdallah, Mohamed A., Burger, Kelli N. , Slettedahl, Seth W. , Smyrk, Thomas C. , Lewis, Jason T., Giakoumopoulos, Maria , Allawi, Hatim T. , Lidgard, Graham P. , Roberts, Lewis R. , Ahlquist, David A. , Kisiel, John B. , V S R Kanipakam, Reddappa, Ghoz, Hassan M, Berger, Calise K. , Foote, Patrick H. , Mahoney, Douglas W. , Roberts, Lewis R , Slettedahl, Seth W , Taylor, William R. , Abdallah, Mohamed A., Lewis, Jason T.

Mayo Clinic

Hepatology | August 31, 2018 | Volume: 69 | Issue: 3 | Pages: 1180-1192

10.1002/hep.30244 | PMID 30168613 Get It

Early detection improves hepatocellular carcinoma (HCC) outcomes, but better noninvasive surveillance tools are needed. We aimed to identify and validate methylated DNA markers (MDMs) for HCC detection. Reduced representation bisulfite sequencing was performed on DNA extracted from 18 HCC and 35 control tissues. Candidate MDMs were confirmed by quantitative methylation‐specific PCR in DNA from independent tissues (74 HCC, 29 controls). A phase I plasma pilot incorporated quantitative allele‐specific real‐time target and signal amplification assays on independent plasma‐extracted DNA from 21 HCC cases and 30 controls with cirrhosis. A phase II plasma study was then performed in 95 HCC cases, 51 controls with cirrhosis, and 98 healthy controls using target enrichment long‐probe quantitative amplified signal (TELQAS) assays. Recursive partitioning identified best MDM combinations. The entire MDM panel was statistically cross‐validated by randomly splitting the data 2:1 for training and testing. Random forest (rForest) regression models performed on the training set predicted disease status in the testing set; median areas under the receiver operating characteristics curve (AUCs; and 95% confidence interval [CI]) were reported after 500 iterations. In phase II, a six‐marker MDM panel (homeobox A1 [HOXA1], empty spiracles homeobox 1 [EMX1], AK055957 , endothelin‐converting enzyme 1 [ECE1], phosphofructokinase [PFKP], and C‐type lectin domain containing 11A [CLEC11A]) normalized by beta‐1,3‐galactosyltransferase 6 (B3GALT6) level yielded a best‐fit AUC of 0.96 (95% CI, 0.93‐0.99) with HCC sensitivity of 95% (88%‐98%) at specificity of 92% (86%‐96%). The panel detected 3 of 4 (75%) stage 0, 39 of 42 (93%) stage A, 13 of 14 (93%) stage B, 28 of 28 (100%) stage C, and 7 of 7 (100%) stage D HCCs. The AUC value for alpha‐fetoprotein (AFP) was 0.80 (0.74‐0.87) compared to 0.94 (0.9‐0.97) for the cross‐validated MDM panel (P < 0.0001). Conclusion : MDMs identified in this study proved to accurately detect HCC by plasma testing. Further optimization and clinical testing of this promising approach are indicated.
Histopathology of granulomatous liver disease
Lewis, Jason

Mayo Clinic

Clinical Liver Disease | April 10, 2018 | Volume: 11 | Issue: 3 | Pages: 77-80

10.1002/cld.695 | PMID 30992794 Get It

Human Gongylonema pulchrum Infection: Esophageal Symptoms and Need for Prolonged Albendazole Therapy
Reza, Mohammed, Peterson, Joy H., Hata, D. Jane , Libertin, Claudia R. , Lewis, Jason

Mayo Clinic

The American Society of Tropical Medicine and Hygiene | January 31, 2017 | Volume: 96 | Issue: 4 | Pages: 873-875

10.4269/ajtmh.16-0852 | PMID 28138043 Get It

We describe a case of human infection with Gongylonema pulchrum acquired in southeast Georgia. The patient presented with intermittent yet persistent nausea and vomiting for months. This case describes the need for extraction of worms on two occasions each followed by courses of albendazole treatment. Gongylonema pulchrum infections with high worm burden may relapse after extraction of the worm and a 3-day short course of albendazole therapy. Longer courses of albendazole may be indicated in selected circumstances.
Symptomatic Ovarian Steroid Cell Tumor not Otherwise Specified in a Post-Menopausal Woman
Sood, Neha, Desai, Kaniksha , Chindris, Ana-Maria, Lewis, Jason, Dinh, Tri A., Chindris, Ana-Maria

Mayo Clinic

Rare Tumors | June 29, 2016 | Volume: 8 | Issue: 2 | Pages: 69-72

10.4081/rt.2016.6200 | PMID 27441075 Get It

Steroid cell tumor not otherwise specified (NOS) is a rare subtype of sex cord stromal tumor of the ovary and contributes less than 0.1% of all ovarian neoplasms. The majority of tumors occur in pre-menopausal women (mean age: 43 years), in which 56-77% of patients present with virilization due to excess testosterone. An 80-year-old woman with worsening alopecia and excessive growth of coarse hair on abdomen and genital area was found to have elevated serum testosterone level (462 ng/mL). Radiologic studies were consistent with bilateral adrenal adenomas. Bilateral adrenal venous sampling ruled out the adrenal gland as origin of hormone secretion. A diagnostic and therapeutic bilateral salpingo-oophorectomy confirmed steroid cell tumor NOS of the left ovary. Post-operatively, the patient had complete resolution of her symptoms and normalization of testosterone level. Our case emphasizes the importance of a clinical suspicion for an occult testosterone secreting ovarian tumor in a symptomatic patient without obvious ovarian mass on imaging.
Androgen Receptor Upregulation Mediates Radioresistance after Ionizing Radiation
Spratt, Daniel E. , Doran, Michael G. , Lee, Man Xia, Shah, Neel , Wongvipat, John, Carnazza, Kathryn E., Klee, George G., Polkinghorn, William R., Tindall, Donald J., Lewis, Jason S. , Davis, Brian J. , Evans, Michael J. , Lee, Man Xia, Sawyers, Charles L. , Spratt, Daniel E

Mayo Clinic

Cancer Research | October 2, 2015 | Volume: 75 | Issue: 22 | Pages: 4688-4696

10.1158/0008-5472.can-15-0892 | PMID 26432404 Get It

Abstract Clinical trials have established the benefit of androgen deprivation therapy (ADT) combined with radiotherapy in prostate cancer. ADT sensitizes prostate cancer to radiotherapy-induced death at least in part through inhibition of DNA repair machinery, but for unknown reasons, adjuvant ADT provides further survival benefits. Here, we show that androgen receptor (AR) expression and activity are durably upregulated following radiotherapy in multiple human prostate cancer models in vitro and in vivo. Moreover, the degree of AR upregulation correlates with survival in vitro and time to tumor progression in animal models. We also provide evidence of AR pathway upregulation, measured by a rise in serum levels of AR-regulated hK2 protein, in nearly 20% of patients after radiotherapy. Furthermore, these men were three-fold more likely to experience subsequent biochemical failure. Collectively, these data demonstrate that radiotherapy can upregulate AR signaling after therapy to an extent that negatively affects disease progression and/or survival. Cancer Res; 75(22); 4688–96. ©2015 AACR.